We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 15, 2019

Everolimus After Hepatic Arterial Embolization of Metastases From Gastrointestinal NETs

European Journal of Cancer

 

Additional Info

European Journal of Cancer
Everolimus After Hepatic Arterial Embolisation Therapy of Metastases From Gastrointestinal Neuroendocrine Tumours: The FFCD 1104-EVACEL-GTE Phase II Study
Eur. J. Cancer 2019 Oct 31;123(xx)92-100, T Walter, C Lepage, R Coriat, E Barbier, G Cadiot, FX Caroli-Bosc, T Aparicio, K Bouhier-Leporrier, O Hentic-Dhome, F Gay, AC Dupont-Gossart, M Duluc, C Lepere, T Lecomte, D Smith, C Petorin, F Di-Fiore, F Ghiringhelli, JL Legoux, R Guimbaud, E Baudin, C Lombard-Bohas, T de Baère

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading